Literature DB >> 18815406

Zoledronic acid infusion and orbital inflammatory disease.

Neil S Sharma, Ju-Lee Ooi, Katherine Masselos, Michael J Hooper, Ian C Francis.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18815406     DOI： 10.1056/NEJMc0803366

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  9 in total

Review 1.  Diffuse ocular and orbital inflammation after zoledronate infusion-case report and review of the literature.

Authors:  Obi C Umunakwe; David Herren; Stephen J Kim; Sahar Kohanim
Journal:  Digit J Ophthalmol       Date:  2017-12-28

Review 2.  Safety of long-term bisphosphonate therapy for the management of osteoporosis.

Authors:  E Michael Lewiecki
Journal:  Drugs       Date:  2011-04-16       Impact factor: 9.546

3.  Therapeutic effect of oral bisphosphonates on choroidal neovascularization in the human eye.

Authors:  Shigeru Honda; Takayuki Nagai; Naoshi Kondo; Masahide Fukuda; Sentaro Kusuhara; Yasutomo Tsukahara; Akira Negi
Journal:  J Ophthalmol       Date:  2010-07-25       Impact factor: 1.909

4.  Orbital inflammatory disease secondary to a single-dose administration of zoledronic acid for treatment of postmenopausal osteoporosis.

Authors:  F Procianoy; E Procianoy
Journal:  Osteoporos Int       Date:  2009-10-27       Impact factor: 4.507

Review 5.  Guidelines for the prevention and treatment of glucocorticoid-induced osteoporosis: an update of Brazilian Society of Rheumatology (2020).

Authors:  Rosa M R Pereira; Mariana O Perez; Ana Patrícia Paula; Caio Moreira; Charlles H M Castro; Cristiano A F Zerbini; Diogo S Domiciano; Elaine de Azevedo; Laura M C Mendonca; Marcia Midore Shinzato; Marco Antonio A da Rocha-Loures; Sebastião Radominski; Vera L Szejnfeld
Journal:  Arch Osteoporos       Date:  2021-03-01       Impact factor: 2.617

6.  Long-term treatment with bisphosphonates and their safety in postmenopausal osteoporosis.

Authors:  Michael Pazianas; Cyrus Cooper; F Hal Ebetino; R Graham G Russell
Journal:  Ther Clin Risk Manag       Date:  2010-07-21       Impact factor: 2.423

7.  Pharyngeal spreading of peri-implant infections under antiresorptive/antiangiogenic therapy.

Authors:  Karsten Kern; Fania Lukmann; Karina Obreja; Sara Al-Maawi; Bellinghausen Carla; Shahram Ghanaati; Gernot Rohde; Robert Sader; Frank Schwarz
Journal:  Int J Implant Dent       Date:  2021-06-03

Review 8.  Orbital Inflammation Caused by Aminobisphosphonates.

Authors:  J Gonzalez Barlatay; C Pagano Boza; G V Hernandez Gauna; J E Premoli
Journal:  J Ophthalmic Vis Res       Date:  2022-01-21

9.  Drug-induced uveitis.

Authors:  Nikolas Js London; Sunir J Garg; Ramana S Moorthy; Emmett T Cunningham
Journal:  J Ophthalmic Inflamm Infect       Date:  2013-03-25
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.